rituximab
celltrion,trion pharmaceuticals
['ritux', 'celltrion', 'trion']
at #ash22, we presented the latest pms study demonstrating efficacy and safety profile of our biosimilar rituximab. at #celltrionhealthcare, we're passionate about #breakingtheboundaries in #bloodcancers.
for more information: 
We go beyond innovation to make people’s lives better. #GuidanceToBetterLife
For guidelines on comments visit:
https://t.co/EHBLUXtFa2